Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

14,476 total articles

Cerebras Repricing: Can Growth Justify a $50B Price Tag?

Cerebras Repricing: Can Growth Justify a $50B Price Tag?

Cerebras is trading like a high-growth AI infrastructure winner: a market cap near $50B against roughly $510M of trailing revenue and quarter-to-quarter acceleration. Recent commercial wins and an AMD partnership have shifted expectations; this trade idea lays out an entry, stop and target for a long position over the next 180 trading days while ma…

Intuit Looks Poised for a Tactical Rebound After the May Pullback

Intuit Looks Poised for a Tactical Rebound After the May Pullback

Intuit's shares have retraced sharply after a weak tax season print and a workforce reduction announcement. Fundamentals - steady cash flow, healthy margins and valuations near 20x FY earnings - argue the worst of the selloff is priced in. Technical momentum and improving moving averages support a tactical long with strict risk controls. This trade…

Bloom Energy: Why This Rally Started To Make Sense After I Ran The Numbers

Bloom Energy: Why This Rally Started To Make Sense After I Ran The Numbers

Bloom Energy's share price has ripped higher in 2026 and looked overheated at face value. After digging into the numbers - strong Q2 revenue, raised guidance, meaningful free cash flow and persistent demand from AI data centers - I think there's an actionable long trade on a measured pullback. The trade balances upside to roughly $300 with a strict…

Prime Medicine: Clinic-Ready Data Could Re-rate this Prime Editing Play

Prime Medicine: Clinic-Ready Data Could Re-rate this Prime Editing Play

Prime Medicine ($3.09) is a high-risk, high-reward gene-editing play trading on a $560M market cap. Recent NEJM publication for PM359 and planned IND/CTA filings for Wilson's Disease and A1AT in 2026-2027, together with a capital raise that extended runway into 2027, create a realistic path to clinical catalysts. We outline a tactical long: entry $…

Nebius After the 10x: Why I’m Still Long and How I’d Trade It

Nebius After the 10x: Why I’m Still Long and How I’d Trade It

Nebius has gone from speculative to systemically important in the AI infrastructure layer. Recent results show rapidly improving profitability and enormous revenue growth; the market is pricing massive execution. I outline a long trade with precise entry, stop and target, explain why the business matters, the valuation framing, catalysts to watch a…

Faraday Copper: A Sensible Speculative Buy on Copper Momentum

Faraday Copper: A Sensible Speculative Buy on Copper Momentum

Faraday Copper offers a high-risk, high-reward way to play a persistent copper deficit and electrification demand. The stock is a speculative buy around current levels with a defined entry, stop, and target. The trade rests on positive drilling news, study progression and financing clarity; failure to hit those milestones or a sustained fall in cop…

Danaher: Buy the 2026 Dip for 2027 Reacceleration

Danaher: Buy the 2026 Dip for 2027 Reacceleration

Danaher is trading near $203 after a sharp, emotion-driven sell-off in July. Fundamentals remain intact: $5.5B in free cash flow, a manageable debt profile, and improving equipment order momentum. If management can convert acquisitions and delayed consumable shipments into organic growth in 2027, upside to the $240s becomes likely. This trade lays …

KLA: Selloff Cleans Out Excess, Reposition Into a Rebound

KLA: Selloff Cleans Out Excess, Reposition Into a Rebound

KLA (KLAC) plunged from its late-June peak in a broad semiconductor correction. Fundamentals remain intact: high free cash flow ($3.77B trailing), strong returns (ROE 76%), and AI-driven capital spending that underpins equipment demand. Technicals show constructive momentum and a more attractive entry near $204. We recommend a swing trade with an e…